Posted: Wednesday, April 7, 2021
Alexander E. Perl, MD, of the Abramson Cancer Center at the University of Pennsylvania, discusses changes to the NCCN Clinical Practice Guidelines in Oncology® for managing acute myeloid leukemia and how he approaches the selection of therapies, as well as financial and treatment-related toxicities.